Response data
| . | Total . | B . | T . |
|---|---|---|---|
| n | 22 | 20 | 2 |
| CR | 14 (64)* | 14 (70) | 0 |
| CRp | 2 (9) | 2 (10) | 0 |
| OR (CR + CRp) | 16 (73)† | 16 (80) | 0 |
| SD/PD | 2 (9) | 0 | 2 (100) |
| Toxic deaths | 3 (14) | 3 (15) | 0 |
| Undetermined‡ | 1 (4.5) | 1 (5) | 0 |
| BM response | |||
| M1 | 17 (77) | 17 (85) | 0 |
| M2/M3 | 2 (9) | 0 | 2 (100) |
| Toxic deaths | 3 (14) | 3 (15) | 0 |
| . | Total . | B . | T . |
|---|---|---|---|
| n | 22 | 20 | 2 |
| CR | 14 (64)* | 14 (70) | 0 |
| CRp | 2 (9) | 2 (10) | 0 |
| OR (CR + CRp) | 16 (73)† | 16 (80) | 0 |
| SD/PD | 2 (9) | 0 | 2 (100) |
| Toxic deaths | 3 (14) | 3 (15) | 0 |
| Undetermined‡ | 1 (4.5) | 1 (5) | 0 |
| BM response | |||
| M1 | 17 (77) | 17 (85) | 0 |
| M2/M3 | 2 (9) | 0 | 2 (100) |
| Toxic deaths | 3 (14) | 3 (15) | 0 |
Values are n (%).
B indicates B-precursor ALL; T, T-cell ALL; CR, complete remission; CRp, complete remission without platelet recovery; M1, < 5% bone marrow blasts; M2, 5%-25% BM blasts; M3, > 25% BM blasts; OR, overall response; PD, progressive disease; and SD, stable disease.
95% exact confidence interval 41%-83%.
95% exact confidence interval 50%-89%.
Response could not be determined: M1 achieved but treated with additional chemotherapy before peripheral recovery.